MMIT’s AIS Health Article Details Efficacy and Costs of Specialty Drugs

MMIT’s AIS Health recently published an article on specialty pharmacy. Employers are typically resistant to drugs commanding high price tags. However, understanding the costs typically associated with disease can lead to better management and the inclusion of drugs that lead to lower long-term costs.

“Employers have long been concerned about costs for specialty therapies, but some are hesitant about putting too many restrictions on them. However, as these drugs continue to come onto the market with higher and higher price tags, experts say employers should become more familiar with these therapies in order to properly manage them.” Read the article here.

(Source: MMIT, 2021)